Thinking About Tocagen

Tocagen received a Breakthrough Therapy designation for its drugs Toca 511 and Toca FC  on Feb 23, 2017.  The drugs purpose is to treat recurrent high grade glioma.  There are approximately 15,000 incidents of high grade glioma in the US.  Toca is an immunotherapy combination with a small molecule supplement.  Basically they release a virus…

Vores uafhængige analyser er tilgængelig mod betaling / This content is for Premium – ALL fundmanagers and David Zickafoose Fundmanager Subscription members only.
Log In Register